Strategic Partnerships Polarean has ongoing collaborations and supply agreements with major healthcare networks and universities (e.g., University of Virginia Health, SimonMed) which indicates a receptive environment for expanded clinical deployments and co-developed imaging programs.

Clinical Adoption FDA-approved Xenon MRI platform and recent clinical upgrades position Polarean as a trusted solution for modern respiratory imaging, presenting a clear case for hospitals and imaging centers to upgrade their pulmonary function assessment capabilities.

Expansion Momentum Active participation in major conferences (ATS RIS, 2025) and supply/customer expansion efforts signal growth opportunities in both academic centers and commercial health systems seeking cutting-edge lung imaging technology.

Financial Leverage Recent funding rounds and a current revenue stream combined with a $12.6M financing event suggest capacity for scaled deployments, regional market expansion, and accelerated installation of Xenon MRI systems.

Integrated Offering Polarean’s end-to-end platform including proprietary Xenon gas blend, hyperpolarization system, software, and accessories enables bundled sales and cross-sell opportunities with radiology, pulmonology, and hospital IT teams seeking a unified imaging workflow.